Pages that link to "Q34452993"
Jump to navigation
Jump to search
The following pages link to Differential cellular responses to exogenous DNA in mammalian cells and its effect on oligonucleotide-directed gene modification (Q34452993):
Displaying 13 items.
- Oligo/Polynucleotide-Based Gene Modification: Strategies and Therapeutic Potential (Q28307657) (← links)
- EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases (Q33848050) (← links)
- Oligonucleotide-mediated gene targeting in human hepatocytes: implications of mismatch repair (Q34254706) (← links)
- Mosaic zebrafish transgenesis for functional genomic analysis of candidate cooperative genes in tumor pathogenesis (Q35461402) (← links)
- Progress and prospects: targeted gene alteration (TGA). (Q36986953) (← links)
- Gene therapy for muscular dystrophy: current progress and future prospects. (Q37519650) (← links)
- Oligonucleotide-directed gene-editing technology: mechanisms and future prospects. (Q37982821) (← links)
- Caffeine suppresses homologous recombination through interference with RAD51-mediated joint molecule formation (Q39153095) (← links)
- DNA mismatch repair proficiency executing 5-fluorouracil cytotoxicity in colorectal cancer cells (Q39495581) (← links)
- Effects of in ovo electroporation on endogenous gene expression: genome-wide analysis. (Q39756221) (← links)
- Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells (Q45875908) (← links)
- The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1. (Q47319323) (← links)
- Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells. (Q53467454) (← links)